Advances in treatment of triple negative breast cancer

Bookmark and Share
Published: 15 Jul 2013
Views: 5194
Rating:
Save
Dr Clifford Hudis - Memorial Sloan-Kettering Cancer Center, New York, USA

Dr Clifford Hudis talks to ecancer at MBCC 15 about triple negative breast cancer and the need to develop subtypes for this specific type of breast cancer in order to develop new targeted therapies.

This is already being done with gene expression profiling and an example where it has been successful is with androgen receptors and treating with the prostate cancer drug bicalutamide.